PYC Therapeutics Limited (ASX:PYC)
Australia · Delayed Price · Currency is AUD 2.040
-0.090 (-4.23%)
Aug 7, 2026, 4:10 PM AEST
PYC Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, PYC Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $3.75. The average 1-year stock price forecast is 83.82% higher than the current stock price, while the lowest is $2.30 (+12.75%) and the highest is $5.00 (+145.10%).
Price Target: $3.75 (+83.82%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PYC Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $2.30 | Buy | Maintains | $2.30 | +12.75% | Jul 30, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $2.84 | Buy | Maintains | $2.84 | +39.22% | Jun 6, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $4.00 → $5.00 | Buy | Maintains | $4.00 → $5.00 | +145.10% | Mar 20, 2026 |
Financial Forecast
Revenue This Year
3.67M
from 23.49M
Decreased by -84.39%
Revenue Next Year
n/a
from 3.67M
Decreased by -100.00%
EPS This Year
-0.07
from -0.10
EPS Next Year
-0.09
from -0.07
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.